Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-01

FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Levothyroxine sodium (generic) from Mylan Pharmaceuticals Inc., authorizing an additional approval under ANDA076…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)